Serum Irisin Predicts Posthepatectomy Complications in Patients with Hepatocellular Carcinoma.

Published in: Disease markers (2019)

Irisin may be a novel serum biomarker in the diagnosis of HCC and a predictor of complications after hepatectomy.

Keyphrases